Arash Shirvani

Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection

Zhila Maghbooli, Mohammad Ali Sahraian, Mehdi Ebrahimi et al. · PLoS ONE · 2020 · 278 citations · Full text

The Effect of Various Doses of Oral Vitamin D₃Supplementation on Gut Microbiota in Healthy Adults: A Randomized, Double-blinded, Dose-response Study

Nipith Charoenngam, Arash Shirvani, Tyler A Kalajian et al. · Anticancer Research · 2019 · 131 citations · Full text

Disassociation of Vitamin D’s Calcemic Activity and Non-calcemic Genomic Activity and Individual Responsiveness: A Randomized Controlled Double-Blind Clinical Trial

Arash Shirvani, Tyler A Kalajian, Anjeli Song et al. · Scientific Reports · 2019 · 111 citations · Full text

Treatment With 25-Hydroxyvitamin D3 (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial

Zhila Maghbooli, Mohammad Ali Sahraian, Saeidreza Jamalimoghadamsiahkali et al. · Endocrine Practice · 2021 · 99 citations · Full text

Long Covid, Pilot Multicenter, Medicine +8

Association of Vitamin D Status With Hospital Morbidity and Mortality in Adult Hospitalized Patients With COVID-19

Nipith Charoenngam, Arash Shirvani, Niyoti Reddy et al. · Endocrine Practice · 2021 · 80 citations · Full text